The Effects of Spironolactone on Calcineurin Inhibitor Induced Nephrotoxicity

NCT01602861 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

188

Enrollment

OTHER

Sponsor class

Conditions

Disorder Related to Renal Transplantation

Interventions

DRUG: Spironolactone
DRUG: placebo

Sponsor

Odense University Hospital

Collaborators

[object Object]